More frequently reported side effects include: hyperthyroidism.  See below for a comprehensive list of adverse effects.
As well as its needed effects, pembrolizumab may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking pembrolizumab, check with your doctor or nurse immediately:
Some pembrolizumab side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
Very common (10% or more): Peripheral edema (up to 17%)
Very common (10% or more): Pruritus (up to 30%), rash (up to 29%), vitiligo (up to 11%)Uncommon (0.1% to 1%): Exfoliative dermatitis
Very common (10% or more): Hyperglycemia (up to 40%), hypertriglyceridemia (up to 25%)Common (1% to 10%): Hypothyroidism, hyperthyroidismUncommon (0.1% to 1%): Hypophysitis, adrenal insufficiency
Very common (10% or more): Nausea (up to 30%), constipation (up to 21%), diarrhea (up to 20%), vomiting (up to 16%), abdominal pain (up to 12%)Common (1% to 10%): ColitisUncommon (0.1% to 1%): Pancreatitis
Very common (10% or more): Anemia (up to 55%), immune-mediated hemolytic anemia
Very common (10% or more): Hypoalbuminemia (up to 34%), increased aspartate aminotransferase (up to 24%)Uncommon (0.1% to 1%): Hepatitis
Very common (10% or more): Hyponatremia (up to 35%), decreased appetite (up to 26%), hypocalcemia (up to 24%)
Very common (10% or more): Arthralgia (up to 20%), pain in extremity (up to 18%), myalgia (up to 14%), back pain (up to 12%)Uncommon (0.1% to 1%): Arthritis, myositis, myasthenic syndrome, rhabdomyolysis
Very common (10% or more): Headache (up to 16%), dizziness (up to 11%)Uncommon (0.1% to 1%): Partial seizures
Uncommon (0.1% to 1%): Uveitis, optic neuritis
Very common (10% or more): Fatigue (up to 47%), chills (up to 14%), pyrexia (up to 11%), sepsis (up to 10%)
Very common (10% or more): Insomnia (up to 14%)
Uncommon (0.1% to 1%): Nephritis, renal failure
Very common (10% or more): Cough (up to 30%), dyspnea (up to 18%), upper respiratory tract infection (up to 11%)Common (1% to 10%): Pneumonitis
It is possible that some side effects of pembrolizumab may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Bloating or swelling of the face, arms, hands, lower legs, or feet
body aches or pain
chills
constipation
cough
depressed mood
difficulty with breathing
difficulty with moving
dry skin and hair
ear congestion
feeling cold
fever
hair loss
headache
hoarseness or husky voice
loss of voice
muscle cramps, pain, and stiffness
pain in the joints
pale skin
rapid weight gain
runny or stuffy nose
slowed heartbeat
sneezing
sore throat
tingling of the hands or feet
trouble breathing
troubled breathing with exertion
unusual bleeding or bruising
unusual tiredness or weakness
unusual weight gain or loss
Chest pain
general feeling of discomfort or illness
nervousness
pain
sensitivity to heat
stomach cramps
sweating
tenderness
thickening of bronchial secretions
trouble sleeping
watery or bloody diarrhea
weight loss
Back, leg, or stomach pains
bleeding gums
blurred vision or other change in vision
cracks in the skin
darkened urine
difficulty with moving
drowsiness
eye pain
fast heartbeat
general body swelling
general tiredness and weakness
indigestion
light-colored stools
loss of appetite
loss of heat from the body
nausea or vomiting
nosebleeds
pain, swelling, or redness in the joints
pains in the stomach, side, or abdomen, possibly radiating to the back
pale skin
red, swollen skin
redness of the eye
scaly skin
seizures
sensitivity of the eye to light
sore throat
tearing
upper right abdominal or stomach pain
yellow eyes and skin
Decreased appetite
diarrhea
dizziness
headache
rash 